News & Articles

Capture higher quality multicolor images more quickly and achieve better quantitative results over the full field of view

The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs

The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline

This recognition occurred at the 2020 NACCHO Annual Conference virtually July 7-9, 2020

Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab

Dr. Emma Walker reveals how transitioning from immunoassays to LC-MS/MS has helped deliver better diagnostic services in her lab

Learn about sample contaminant detection, an important step towards nucleic acid quantification

Join us on Tuesday, July 28, to learn about the structural link between COVID-19 pathology and the virus itself and how this may lead to novel therapeutics

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine

The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand

Virologist Dr. Ryan McNamara discusses viral hijacking of extracellular vesicles and its potential for informing novel biotherapeutics

Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan

GeneX India Biosciences takes over sole distribution activities in India and IT Technologies will operate in Singapore and Malaysia

The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector

This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19

QC-validated cell lines promise to simplify and accelerate CRISPR gene editing workflows